אוגמנטין תרחיף 125 מ"ג/5 מ"ל

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

AMOXICILLIN AS TRIHYDRATE 125 MG / 5 ML; CLAVULANIC ACID AS POTASSIUM 31.25 MG / 5 ML

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

J01CR01

forme pharmaceutique:

SUSPENSION

Mode d'administration:

PER OS

Fabriqué par:

SMITHKLINE BEECHAM PLC, UK

Groupe thérapeutique:

AMPICILLIN AND ENZYME INHIBITOR

indications thérapeutiques:

Fot the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused also by beta-lactamase producing organisms which are susceptible to Augmentin and are resistant to other beta-lactam antibiotics.

Date de l'autorisation:

2012-09-01